| Opinion on the diagnosis and treatment of human trichinellosis F Bruschi, J Dupouy-Camet, W Kociecka, E Pozio, F Bolas-Fernandez Expert opinion on pharmacotherapy 3 (8), 1117-1130, 2002 | 351 | 2002 |
| Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale R Fernández-García, A Lalatsa, L Statts, F Bolás-Fernández, ... International journal of pharmaceutics 573, 118817, 2020 | 202 | 2020 |
| HP-Lattice QSAR for dynein proteins: Experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence MA Dea-Ayuela, Y Pérez-Castillo, A Meneses-Marcel, FM Ubeira, ... Bioorganic & medicinal chemistry 16 (16), 7770-7776, 2008 | 111 | 2008 |
| Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins R Concu, MA Dea-Ayuela, LG Perez-Montoto, F Bolas-Fernandez, ... Journal of Proteome Research 8 (9), 4372-4382, 2009 | 91 | 2009 |
| New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp HK Ruiz, DR Serrano, MA Dea-Ayuela, PE Bilbao-Ramos, ... International journal of pharmaceutics 473 (1-2), 148-157, 2014 | 88 | 2014 |
| Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations DR Serrano, L Hernández, L Fleire, I González-Alvarez, A Montoya, ... International journal of pharmaceutics 447 (1-2), 38-46, 2013 | 83 | 2013 |
| 3D entropy and moments prediction of enzyme classes and experimental-theoretic study of peptide fingerprints in Leishmania parasites R Concu, MA Dea-Ayuela, LG Perez-Montoto, FJ Prado-Prado, E Uriarte, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1794 (12), 1784-1794, 2009 | 83 | 2009 |
| In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum L Ordónez-Gutiérrez, R Espada-Fernández, MA Dea-Ayuela, JJ Torrado, ... International Journal of Antimicrobial Agents 30 (4), 325-329, 2007 | 80 | 2007 |
| Quantitative determination of albendazole and its main metabolites in plasma JJ Garcia, F Bolás-Fernández, JJ Torrado Journal of Chromatography B: Biomedical Sciences and Applications 723 (1-2 …, 1999 | 69 | 1999 |
| The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives E Castillo, M A Dea-Ayuela, F Bolás-Fernández, M Rangel, ... Current medicinal chemistry 17 (33), 4027-4051, 2010 | 68 | 2010 |
| Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity JJ García-Rodriguez, PM de la Torre-Iglesias, MC Vegas-Sánchez, ... International journal of pharmaceutics 403 (1-2), 23-28, 2011 | 67 | 2011 |
| TSL-1 antigens of Trichinella: an overview of their potential role in parasite invasion, survival and serodiagnosis of trichinellosis F Bolas-Fernandez, L del Corral Bezara Research in Veterinary Science 81 (3), 297-303, 2006 | 67 | 2006 |
| Proteomic analysis of antigens from Leishmania infantum promastigotes MA Dea‐Ayuela, S Rama‐Iñiguez, F Bolás‐Fernández Proteomics 6 (14), 4187-4194, 2006 | 66 | 2006 |
| Enhanced susceptibility to Trichuris muris infection of B10Br mice treated with the probiotic Lactobacillus casei MA Dea-Ayuela, S Rama-Iñiguez, F Bolás-Fernandez International immunopharmacology 8 (1), 28-35, 2008 | 65 | 2008 |
| Generalized lattice graphs for 2D-visualization of biological information H Gonzalez-Diaz, LG Perez-Montoto, A Duardo-Sanchez, E Paniagua, ... Journal of theoretical biology 261 (1), 136-147, 2009 | 63 | 2009 |
| Oral fixed-dose combination pharmaceutical products: Industrial manufacturing versus personalized 3D printing R Fernández-García, M Prada, F Bolás-Fernández, MP Ballesteros, ... Pharmaceutical research 37, 1-22, 2020 | 58 | 2020 |
| In Vitro and in Vivo Antileishmanial and Trypanocidal Studies of New N-Benzene- and N-Naphthalenesulfonamide Derivatives C Galiana-Rosello, P Bilbao-Ramos, MA Dea-Ayuela, M Rolon, C Vega, ... Journal of medicinal chemistry 56 (22), 8984-8998, 2013 | 53 | 2013 |
| In vivo and in vitro anti-leishmanial activities of 4-nitro-N-pyrimidin-and N-pyrazin-2-ylbenzenesulfonamides, and N2-(4-nitrophenyl)-N1-propylglycinamide MA Dea-Ayuela, E Castillo, M Gonzalez-Alvarez, C Vega, M Rolón, ... Bioorganic & medicinal chemistry 17 (21), 7449-7456, 2009 | 51 | 2009 |
| Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis L Smith, DR Serrano, M Mauger, F Bolás-Fernández, MA Dea-Ayuela, ... Molecular Pharmaceutics 15 (7), 2570-2583, 2018 | 49 | 2018 |
| Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice ML Lopez-Garcia, S Torrado-Duran, J Torrado-Duran, ... International journal for parasitology 27 (7), 781-785, 1997 | 48 | 1997 |
